Renaissance Technologies - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 67 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$50
-88.1%
71,700
-84.7%
0.00%
-100.0%
Q1 2023$419
+15.4%
467,682
+52.2%
0.00%
Q4 2022$363
-100.0%
307,300
+131.3%
0.00%
-100.0%
Q3 2021$888,000
+210.5%
132,884
+295.2%
0.00%
Q2 2021$286,000
-69.8%
33,625
-68.5%
0.00%
-100.0%
Q1 2021$946,000
-48.7%
106,884
-60.6%
0.00%
-50.0%
Q1 2020$1,844,000
-13.5%
271,184
+89.5%
0.00%0.0%
Q4 2019$2,133,000
+3.3%
143,129
-28.9%
0.00%0.0%
Q3 2019$2,064,000
-34.8%
201,329
-32.6%
0.00%
-33.3%
Q2 2019$3,165,000
-18.8%
298,613
+7.1%
0.00%
-25.0%
Q1 2019$3,899,000
+51.6%
278,929
+10.2%
0.00%
+33.3%
Q4 2018$2,572,000
-23.1%
253,129
-9.2%
0.00%0.0%
Q3 2018$3,346,000
-24.4%
278,813
-29.3%
0.00%
+50.0%
Q2 2018$4,425,000
+173.8%
394,258
+140.4%
0.00%0.0%
Q1 2018$1,616,000
+19.4%
164,029
+69.1%
0.00%
+100.0%
Q4 2017$1,353,000
+55.7%
97,013
+22.8%
0.00%0.0%
Q3 2017$869,000
+369.7%
79,013
+237.3%
0.00%
Q2 2017$185,00023,4250.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$20,462,0006.02%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$18,315,0003.89%
NEXTHERA CAPITAL LP 263,600$3,018,0001.54%
SPHERA FUNDS MANAGEMENT LTD. 385,301$4,412,0000.86%
RA Capital Management 354,200$4,056,0000.50%
DAFNA Capital Management LLC 35,977$412,0000.35%
Boxer Capital, LLC 138,331$1,584,0000.35%
SABBY MANAGEMENT, LLC 238,907$2,735,0000.15%
Monashee Investment Management LLC 31,500$361,0000.14%
Lombard Odier Asset Management (USA) Corp 100,000$1,145,0000.11%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders